Clinical Trial Update: Use of Magnetic Field Mapping in the Evaluation of Patients With Hypertrophic Heart Disease (Thick Heart Muscle)

View source ↗

Summary

The trial NCT00574821 evaluating magnetic field mapping for hypertrophic cardiomyopathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Hypertrophic Cardiomyopathy | Status: WITHDRAWN